Cushing's Syndrome Terminated Phase 2 Trials for Nevanimibe (DB16254)

Also known as: Cushing Syndrome / Cushing’s syndrome / Cushings syndrome / Syndrome Cushing's

IndicationStatusPhase
DBCOND0028130 (Cushing's Syndrome)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03053271A Study of ATR-101 for the Treatment of Endogenous Cushing's SyndromeTreatment